UA91330C2 - 1,1,1- TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO[2,3-c]PYRIDIN-2-YLMETHYL)PENTAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS GLUCOCORTICOID LIGANDS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DIABETES - Google Patents

1,1,1- TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO[2,3-c]PYRIDIN-2-YLMETHYL)PENTAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS GLUCOCORTICOID LIGANDS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DIABETES

Info

Publication number
UA91330C2
UA91330C2 UAA200604365A UAA200604365A UA91330C2 UA 91330 C2 UA91330 C2 UA 91330C2 UA A200604365 A UAA200604365 A UA A200604365A UA A200604365 A UAA200604365 A UA A200604365A UA 91330 C2 UA91330 C2 UA 91330C2
Authority
UA
Ukraine
Prior art keywords
pentan
pyrrolo
ylmethyl
trifluoro
pyridin
Prior art date
Application number
UAA200604365A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Йонес Беккали
Раджашекхар Бетагери
Майкл Дж. Эммануэл
Абдельхаким Хаммач
Кристиан Х.Ю.Й. Харкен
Томас Мартин Киррейн
Дениэл Кузмич
Томас Вай-Хо Ли
Пингронг Лиу
Уша Р. Пател
Хоссейн Разави
Дорис Ритхер
Хиденори Такахаши
Девид С. Томсон
Джи Вонг
Рене Зинделл
Джон Роберт Праудфут
Original Assignee
Бёрингер Ингельхайм Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Фармасьютикалз, Инк. filed Critical Бёрингер Ингельхайм Фармасьютикалз, Инк.
Publication of UA91330C2 publication Critical patent/UA91330C2/en

Links

Abstract

Compounds of Formula (IA), IB), (IC), and (ID) wherein R, R, R, R, R, and Rare as respectively defined herein for Formula (IA), (IB), (IC), and (ID), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.(IA)(IB)(IC)(ID)
UAA200604365A 2003-09-24 2004-09-22 1,1,1- TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO[2,3-c]PYRIDIN-2-YLMETHYL)PENTAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS GLUCOCORTICOID LIGANDS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DIABETES UA91330C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50545603P 2003-09-24 2003-09-24

Publications (1)

Publication Number Publication Date
UA91330C2 true UA91330C2 (en) 2010-07-26

Family

ID=38126280

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200604365A UA91330C2 (en) 2003-09-24 2004-09-22 1,1,1- TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO[2,3-c]PYRIDIN-2-YLMETHYL)PENTAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS GLUCOCORTICOID LIGANDS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DIABETES

Country Status (3)

Country Link
CN (1) CN1976705B (en)
UA (1) UA91330C2 (en)
ZA (1) ZA200600316B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8138189B2 (en) * 2009-03-26 2012-03-20 Hoffman-La Roche Inc. Substituted benzene compounds as modulators of the glucocorticoid receptor

Also Published As

Publication number Publication date
CN1976705B (en) 2010-09-22
ZA200600316B (en) 2007-09-26
CN1976705A (en) 2007-06-06

Similar Documents

Publication Publication Date Title
SG146694A1 (en) 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo-2,3-c pyridin-2- ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes
RS20050174A (en) -3(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
RS82804A (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions,and uses thereof
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
MY135423A (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
ATE346058T1 (en) GLUCOCORTICOID MIMETICS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL FORMULATIONS CONTAINING THEM AND USES THEREOF
AU2003259747A8 (en) Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2006011050A3 (en) Pyridine derivatives
WO2003101932A3 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
MXPA05013712A (en) Propionic acid derivatives useful in the treatment of lipid disorders.
IL229136A (en) Process for preparation of mek inhibitors
MXPA06009475A (en) Quinazoline derivatives and therapeutic use thereof.
MXPA05013349A (en) 2-aminopyrimidine derivatives as raf kinase inhibitors.
WO2005095401A8 (en) Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
BR0014596A (en) Pyrimidine derivative, use of it, pharmaceutical composition, and method of treating cytokine-mediated diseases or medical conditions
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
IL185611A0 (en) Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
WO2005105753A8 (en) Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
WO2004044174A3 (en) Topoisomerase-targeting agents
UA91330C2 (en) 1,1,1- TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO[2,3-c]PYRIDIN-2-YLMETHYL)PENTAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS GLUCOCORTICOID LIGANDS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DIABETES
IL181666A0 (en) Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof
WO2003080624A3 (en) Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
SG149051A1 (en) Nicotinic acetylcholine receptor ligands
SG149052A1 (en) Nicotinic acetylcholine receptor ligands
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them